Edition:
United Kingdom

Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

82.47USD
17 Jul 2019
Change (% chg)

-- (--)
Prev Close
$82.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
426,584
52-wk High
$106.69
52-wk Low
$79.15

Select another date:

Tue, May 28 2019

BioMarin says data shows hemophilia gene therapy effects could wane

BioMarin Pharmaceutical Inc said on Tuesday early trial data for its gene therapy for hemophilia A suggested the one-time infusion's effect on some patients' bleeding disorders would last eight years.

UPDATE 3-BioMarin says data shows hemophilia gene therapy effects could wane

May 28 BioMarin Pharmaceutical Inc said on Tuesday early trial data for its gene therapy for hemophilia A suggested the one-time infusion's effect on some patients' bleeding disorders would last eight years.

BRIEF-BioMarin Says Payers Unlikely To Accept Price Equivalent To Over 5 Years Of Standard Treatment Costs For Hemophilia Gene Therapy

* BIOMARIN CEO SAYS BELIEVES ONCE HEMOPHILIA GENE THERAPY IS APPROVED CO WILL BE IN 'PRETTY GOOD SHAPE' FOR DISCUSSION ON PRICE WITH PAYERS BASED ON FIVE YEARS OF COSTS, SIMILAR TO NOVARTIS

Select another date: